The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients
Published 2008 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients
Authors
Keywords
-
Journal
Diabetes & Vascular Disease Research
Volume 5, Issue 4, Pages 319-335
Publisher
SAGE Publications
Online
2008-10-28
DOI
10.3132/dvdr.2008.046
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Joint Effects of Physical Activity and Body Mass Index on Coronary Heart Disease Risk in Women
- (2008) Amy R. Weinstein et al. ARCHIVES OF INTERNAL MEDICINE
- Fenofibrate reduces fasting and postprandial inflammatory responses among hypertriglyceridemia patients with the metabolic syndrome
- (2008) Robert S. Rosenson et al. ATHEROSCLEROSIS
- α-Linolenic Acid and Risk of Nonfatal Acute Myocardial Infarction
- (2008) Hannia Campos et al. CIRCULATION
- Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation
- (2008) J. D. Brunzell et al. DIABETES CARE
- Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study
- (2008) T. M. E. Davis et al. DIABETOLOGIA
- Cardiovascular risk assessment in the metabolic syndrome: results from the Prospective Cardiovascular Munster (PROCAM) Study
- (2008) G Assmann et al. INTERNATIONAL JOURNAL OF OBESITY
- Effect of Rimonabant on Progression of Atherosclerosis in Patients With Abdominal Obesity and Coronary Artery Disease
- (2008) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes
- (2008) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Increased lipolysis by secretory phospholipase A2group V of lipoproteins in diabetic dyslipidaemia
- (2008) C. Pettersson et al. JOURNAL OF INTERNAL MEDICINE
- Impact of Triglyceride Levels Beyond Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome in the PROVE IT-TIMI 22 Trial
- (2008) Michael Miller et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
- (2008) LANCET
- Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis
- (2008) Anne B. Rossebø et al. NEW ENGLAND JOURNAL OF MEDICINE
- Analyses of Cancer Data from Three Ezetimibe Trials
- (2008) Richard Peto et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ezetimibe and Cancer — An Uncertain Association
- (2008) Jeffrey M. Drazen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
- (2008) Peter Gæde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity
- (2007) Juliana A. de Souza et al. ATHEROSCLEROSIS
- Coronary heart disease trends in England and Wales from 1984 to 2004: concealed levelling of mortality rates among young adults
- (2007) M O'Flaherty et al. HEART
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started